@jitcancer : Let’s take a closer look at recent #JITC article: “rhIL-7-hyFc, a long-acting interleukin-7, improves efficacy of CAR-T cell therapy in solid tumors” by @MitchellHo & @danli_5502 from @NCIResearchCtr & @NeoImmuneTech. 1/8 • TwiCopy

@jitcancer

+ Follow

The official journal of @SITCancer, covering all aspects of tumor immunology and cancer immunotherapy. #JITC Editor-in-Chief: Michael T. Lotze, MD

ID: 1150769339466952705

linkhttps://jitc.bmj.com/ calendar_today15-07-2019 14:09:25

5,5K Tweet

8,8K Takipçi

1,1K Takip Edilen

22 days ago

Let’s take a closer look at recent #JITC article: “rhIL-7-hyFc, a long-acting interleukin-7, improves efficacy of CAR-T cell therapy in solid tumors” by Mitchell Ho, PhD & Dan Li from NCI Center for Cancer Research & NeoImmuneTech. 1/8